
    
      Cystic fibrosis transmembrane regulator (CFTR) biomarker (intestinal current measurement
      (ICM), nasal potential difference (NPD), sweat chloride) before the start of therapy and 12
      and 52 weeks after initiation of therapy Clinical parameters (anthropometry, lung function,
      lung magnetic resonance imaging (MRI), lung computer tomography (CT)) before the start of
      therapy and after initiation of therapy Assessment of airway secretion specimens before the
      start of therapy and after initiation of therapy
    
  